Fig. 4

Total abundance of Alpha-1-antichymotrypsin in the CSF (A) and serum (B) of patients diagnosed with Relapse–remitting multiple sclerosis (RRMS), non-inflammatory diseases of the CNS (N-INF), and with other inflammatory diseases of the CNS (INF), and further sub-divided by gender. The results represent the mean ± SEM and statistical analysis was performed by one-way ANOVA followed by the Tukey’s multiple comparison test, comparing all the indicated conditions (ns, p > 0.05; *p ˂ 0.05, **p ˂ 0.01, ***p < 0.001)